Mar 26
Beyond the Scissors: 5 Surprising Realities of the CRISPR Revolution in 2026
To watch a concise video on this topic, click here 1. Introduction: The Blueprint is Finally Being Rewritten For a decade, CRISPR remained the “perpetual promise” of biotechnology—a laboratory breakthrough stalled by regulatory caution and unfulfilled hype. That narrative ended decisively with the 2024 milestone approval of Casgevy, the first CRISPR-based therapy from CRISPR Therapeutics and…
View On WordPress